Stay updated with breaking news from James Lu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The partnership will leverage Helix's whole-exome sequencing platform and incorporate Qiagen's biopharma relationships, NGS capabilities, and global regulatory expertise.
Partnership to leverage the Helix® Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise Addressing...
Partnership to leverage the Helix Laboratory Platform powered by QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise Addressing health burden in neuro-degenerative
/PRNewswire/ -- TuSimple (Nasdaq: TSP), a global autonomous driving technology company, today announced additional independent appointments to its Board of...
/PRNewswire/ -- TuSimple (Nasdaq: TSP), a global autonomous driving technology company, today announced the appointment of James Lu to its Board of Directors...